BIT — Biotron Cashflow Statement
0.000.00%
- AU$6.64m
- AU$5.70m
Annual cashflow statement for Biotron, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -3.49 | -2.62 | -2.95 | -3.55 | -0.723 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.41 | -2.44 | -3.29 | -3.57 | -0.566 |
| Capital Expenditures | -0.006 | 0 | 0 | 0 | -0.003 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.006 | 0 | 0 | 0 | -0.003 |
| Financing Cash Flow Items | 0 | — | -0.428 | — | -0.167 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.037 | -0.033 | 5.53 | -0.023 | 1.11 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.45 | -2.47 | 2.24 | -3.59 | 0.538 |